Skip to content

Motor Control Exercise Program for Pregnant Women With a History of Lumbopelvic Pain

Effects of a Motor Control Exercise Program on Lumbopelvic Pain Occurrence and Intensity in Pregnant Women With a History of Lumbopelvic Pain: a Study Protocol for a Randomized Controlled Feasibility Trial.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04253717
Enrollment
32
Registered
2020-02-05
Start date
2021-04-02
Completion date
2022-12-14
Last updated
2023-05-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Lumbopelvic Pain

Keywords

Physical activity, Non-invasive treatment

Brief summary

This study protocol was designed to establish the feasibility of conducting a motor control exercise program with pregnant women presenting a history of lumbopelvic pain (LBPP) in order to reduce LBPP occurrence or limit its intensity. This randomized controlled trial also aims to preliminary assess the effectiveness of the program. To do so, 40 pregnant women with a history of LBPP will be recruited and randomly allocated to one of 2 groups: control (20 participants) or intervention (20 participants). The control group will receive standard care, including basic information on what to do when suffering from LBPP. The intervention group will participate in a weekly 40-minute group session and two more 40-minute weekly home exercise sessions. The motor control exercise program will be designed to target strengthening of the lumbo-pelvic-hip core muscles in order to improve stabilization and protection of the spine and pelvis. Participants of this group will also receive standard care. Adequate prevention and treatment of LBPP, experienced by women during pregnancy, should help reduce LBPP occurrence or limit its intensity during pregnancy.

Interventions

OTHERMotor control exercise program

Structure physical training aimed at strengthening muscles of the lumbo-pelvic-hip core complex in order to improve stabilization and alignment of the spine and pelvis.

Sponsors

Université du Québec à Trois-Rivières
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
No

Inclusion criteria

* Being pregnant of one fetus * Being ≤ 20 weeks pregnant * Presenting a history of lumbopelvic pain

Exclusion criteria

* Inflammatory rheumatic disease * Infectious disease * Neuromuscular disease * Vascular disease * Connective tissue disease * Severe disabling pain * Neurologic signs and symptoms

Design outcomes

Primary

MeasureTime frameDescription
Recruitment rateBaseline (Pre-intervention)Defined as the ability to recruit 40 eligible women, willing to participate to the study
Retention rateBaseline (Post-intervention)Defined as the completion of follow-up questionnaire by ≥ 80% of women
Adherence rateBaseline (Post-intervention)Defined as attendance to ≥75% of group sessions and ≥ 75% completion of home sessions
Safety of the intervention16 weeks follow-upDetermined based on the number of adverse events and defined as nature of adverse events
Acceptability of the intervention16 weeks follow-upDetermined based on how the intervention is perceived by pregnant women (assessed using a 5-point Likert scale : higher score mean a better outcome)

Secondary

MeasureTime frameDescription
Lumbopelvic pain (incidence and frequency)Baseline (Pre-intervention)Defined as a weekly self-reported incidence and frequency of lumbopelvic pain (determined based on the number of episode)
Functional disabilityBaseline (Pre-intervention) and week 16 (Post-intervention)Assessed using the Pelvic Girdle Questionnaire (PGQ) (score range from 0 (minimum) to 75 (maximum) : higher score mean a worst outcome)
Lumbopelvic pain (intensity)Baseline (Pre-intervention)Defined as a weekly self-reported intensity of lumbopelvic pain using a 100 millimeters visual analog scale
Fear avoidance behaviorsBaseline (Pre-intervention) and week 16 (Post-intervention)Assessed using the Tampa Scale of Kinesiophobia (TSK) (score range from 17 (minimum) to 68 (maximum) : higher score mean a worst outcome)
Level of anxietyBaseline (Pre-intervention) and week 16 (Post-intervention)Assessed using the State-Trait Anxiety Inventory (STAI) (score range from 20 (minimum) to 80 (maximum) : higher score mean a worst outcome)
DepressionBaseline (Pre-intervention) and week 16 (Post-intervention)Assessed using the Beck Depression Inventory (BDI) (score range from 0 (minimum) to 63 (maximum) : higher score mean a worst outcome)
Physical activity levelsBaseline (Pre-intervention) and week 16 (Post-intervention)Assessed using the Pregnancy Physical Activity Questionnaire (PPAQ) (weekly energy expenditure (MET-h·week-1), score range from 0 (minimum) to 1631 (maximum) : higher score mean a more active person)

Countries

Canada

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jun 1, 2026